Free preview
LAQ Comprehensive
MD Pharmacology NMC syllabus Full notes Recent advances last updated on 2026-06-20

Declaration of Helsinki and Ethical Principles in Research

The WMA charter of ethical principles for medical research involving human participants

Past RGUHS · 4 RGUHSMay '25 RGUHSMay '22 RGUHSJun '16 RGUHSApr '08

Declaration of Helsinki and Ethical Principles in Research

1. Definition, scope and authority

  • The Declaration of Helsinki (DoH) is a statement of ethical principles for medical research involving human participants, including research using identifiable human material or data, developed by the World Medical Association (WMA) (WMA-DoH 2024, Preamble). It is the most widely cited, authoritative, profession-derived statement of research ethics in medicine.
  • It is adopted by physicians, but the WMA holds that the principles "should be upheld by all individuals, teams, and organizations involved in medical research" — applying to both patients and healthy volunteers (WMA-DoH 2024, Preamble). [⚠ 2013→2024 broadening: the 2013 text was "addressed primarily to physicians"; the 2024 revision explicitly extends the moral reach to the whole research team — WMA-DoH 2013 ¶2 vs WMA-DoH 2024 Preamble.]
  • Title change (2024): the document is now "Ethical Principles for Medical Research Involving Human Participants" — replacing "Human Subjects" used through the 2013 revision; "participants" signals an active, respected partner rather than a passive object of study (WMA-DoH 2024, title vs WMA-DoH 2013, title). Browner likewise notes the deliberate move from "subjects" to "participants" (Browner 5e Ch.7, p.5).
  • Legal status — guidance, not law. Even the 1964 original stressed the standards "are only a guide to physicians all over the world… not relieved from criminal, civil and ethical responsibilities under the laws of their own countries" (WMA-DoH 1964, Introduction). The DoH carries enormous moral and regulatory weight (it is referenced by ICH-GCP, the CIOMS guidelines, national regulators and journal editors) but is not itself a statute — it acquires legal force only when incorporated into national regulation (e.g. India's New Drugs and Clinical Trials Rules, the US Common Rule, the EU Clinical Trials Regulation).
  • "Read as a whole" rule: the Declaration "is intended to be read as a whole, and each of its constituent paragraphs should be applied with consideration of all other relevant paragraphs" (WMA-DoH 2024 & 2013, Preamble) — no single article may be quoted in isolation to justify an exception.
  • Primacy-of-participant doctrine (the moral core): the purpose of research is to generate knowledge and advance health, but "these purposes can never take precedence over the rights and interests of individual research participants" (WMA-DoH 2024, General Principles ¶8; WMA-DoH 2013 ¶8). Bennett & Brown quote the Edinburgh-2000 formulation: "considerations related to the well-being of the human subject should take precedence over the interests of science and society" (Bennett & Brown 12e Ch.4, p.37).
  • Why a postgraduate must know it: every research protocol, every Institutional Ethics Committee (IEC) submission, every informed-consent document and every clinical-trial publication is expected to declare conformity with the Declaration of Helsinki — Medhi states the protocol's ethical-considerations section "must state the ethical considerations in accordance with the Helsinki Declaration" (Medhi Ch.8, p. "Ethical Considerations").
Continue reading

Declaration Of Helsinki

PharmaNotes Pro · Comprehensive

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.